Molecular identification of human glutamine- and ammonia-dependent NAD synthetases. Carbon-nitrogen hydrolase domain confers glutamine dependency - PubMed (original) (raw)
. 2003 Mar 28;278(13):10914-21.
doi: 10.1074/jbc.M209203200. Epub 2003 Jan 23.
Affiliations
- PMID: 12547821
- DOI: 10.1074/jbc.M209203200
Free article
Molecular identification of human glutamine- and ammonia-dependent NAD synthetases. Carbon-nitrogen hydrolase domain confers glutamine dependency
Nobumasa Hara et al. J Biol Chem. 2003.
Free article
Erratum in
- J Biol Chem. 2003 Oct 17;278(42):41572
Abstract
NAD synthetase catalyzes the final step in the biosynthesis of NAD. In the present study, we obtained cDNAs for two types of human NAD synthetase (referred as NADsyn1 and NADsyn2). Structural analysis revealed in both NADsyn1 and NADsyn2 a domain required for NAD synthesis from ammonia and in only NADsyn1 an additional carbon-nitrogen hydrolase domain shared with enzymes of the nitrilase family that cleave nitriles as well as amides to produce the corresponding acids and ammonia. Consistent with the domain structures, biochemical assays indicated (i) that both NADsyn1 and NADsyn2 have NAD synthetase activity, (ii) that NADsyn1 uses glutamine as well as ammonia as an amide donor, whereas NADsyn2 catalyzes only ammonia-dependent NAD synthesis, and (iii) that mutant NADsyn1 in which Cys-175 corresponding to the catalytic cysteine residue in nitrilases was replaced with Ser does not use glutamine. Kinetic studies suggested that glutamine and ammonia serve as physiological amide donors for NADsyn1 and NADsyn2, respectively. Both synthetases exerted catalytic activity in a multimeric form. In the mouse, NADsyn1 was seen to be abundantly expressed in the small intestine, liver, kidney, and testis but very weakly in the skeletal muscle and heart. In contrast, expression of NADsyn2 was observed in all tissues tested. Therefore, we conclude that humans have two types of NAD synthetase exhibiting different amide donor specificity and tissue distributions. The ammonia-dependent synthetase has not been found in eucaryotes until this study. Our results also indicate that the carbon-nitrogen hydrolase domain is the functional domain of NAD synthetase to make use of glutamine as an amide donor in NAD synthesis. Thus, glutamine-dependent NAD synthetase may be classified as a possible glutamine amidase in the nitrilase family. Our molecular identification of NAD synthetases may prove useful to learn more of mechanisms regulating cellular NAD metabolism.
Similar articles
- The reported human NADsyn2 is ammonia-dependent NAD synthetase from a pseudomonad.
Bieganowski P, Brenner C. Bieganowski P, et al. J Biol Chem. 2003 Aug 29;278(35):33056-9. doi: 10.1074/jbc.M302276200. Epub 2003 May 30. J Biol Chem. 2003. PMID: 12777395 - Eukaryotic NAD+ synthetase Qns1 contains an essential, obligate intramolecular thiol glutamine amidotransferase domain related to nitrilase.
Bieganowski P, Pace HC, Brenner C. Bieganowski P, et al. J Biol Chem. 2003 Aug 29;278(35):33049-55. doi: 10.1074/jbc.M302257200. Epub 2003 May 27. J Biol Chem. 2003. PMID: 12771147 - Glutamine amidotransferase activity of NAD+ synthetase from Mycobacterium tuberculosis depends on an amino-terminal nitrilase domain.
Bellinzoni M, Buroni S, Pasca MR, Guglierame P, Arcesi F, De Rossi E, Riccardi G. Bellinzoni M, et al. Res Microbiol. 2005 Mar;156(2):173-7. doi: 10.1016/j.resmic.2004.08.011. Res Microbiol. 2005. PMID: 15748981 - Carbamyl phosphate synthetase III, an evolutionary intermediate in the transition between glutamine-dependent and ammonia-dependent carbamyl phosphate synthetases.
Hong J, Salo WL, Lusty CJ, Anderson PM. Hong J, et al. J Mol Biol. 1994 Oct 14;243(1):131-40. doi: 10.1006/jmbi.1994.1638. J Mol Biol. 1994. PMID: 7932737 Review. - [Microbial NAD synthetase and its inhibitors--a review].
Bi J, Wang H, Xie J. Bi J, et al. Wei Sheng Wu Xue Bao. 2011 Mar;51(3):305-12. Wei Sheng Wu Xue Bao. 2011. PMID: 21604544 Review. Chinese.
Cited by
- Regulation of CD73 on NAD metabolism: Unravelling the interplay between tumour immunity and tumour metabolism.
Zhan J, Huang L, Niu L, Lu W, Sun C, Liu S, Ding Z, Li E. Zhan J, et al. Cell Commun Signal. 2024 Aug 1;22(1):387. doi: 10.1186/s12964-024-01755-y. Cell Commun Signal. 2024. PMID: 39090604 Free PMC article. Review. - Inhibitors of NAD+ Production in Cancer Treatment: State of the Art and Perspectives.
Ghanem MS, Caffa I, Monacelli F, Nencioni A. Ghanem MS, et al. Int J Mol Sci. 2024 Feb 8;25(4):2092. doi: 10.3390/ijms25042092. Int J Mol Sci. 2024. PMID: 38396769 Free PMC article. Review. - NAD+ Metabolism and Interventions in Premature Renal Aging and Chronic Kidney Disease.
Chanvillard L, Tammaro A, Sorrentino V. Chanvillard L, et al. Cells. 2022 Dec 21;12(1):21. doi: 10.3390/cells12010021. Cells. 2022. PMID: 36611814 Free PMC article. Review. - Nicotinamide Adenine Dinucleotide (NAD) Metabolism as a Relevant Target in Cancer.
Navas LE, Carnero A. Navas LE, et al. Cells. 2022 Aug 24;11(17):2627. doi: 10.3390/cells11172627. Cells. 2022. PMID: 36078035 Free PMC article. Review. - NAD+ Precursors: A Questionable Redundancy.
Canto C. Canto C. Metabolites. 2022 Jul 9;12(7):630. doi: 10.3390/metabo12070630. Metabolites. 2022. PMID: 35888754 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials